Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.
Estrogen and progesterone are the defining hormones of normal female development, and both play critical roles in breast carcinogenesis. Cyclin D1 is a breast cancer oncogene whose amplification is linked to poor prognosis in estrogen and progesterone receptor-positive breast cancers. Here we report that cyclin D1 regulates progesterone receptor expression, consequently enhancing responses to estrogen and progesterone. Estrogen treatment of cyclin D1 transgenic mice increased progesterone receptor expression and induced mammary hyperplasias that were stimulated by progesterone and blocked by a progesterone antagonist. Progesterone receptor levels decreased in cyclin D1 knockout mice. Cyclin D1 regulated progesterone receptor expression through a novel estrogen- and cyclin D1-responsive enhancer in DNA encoding part of the 3' untranslated region of the progesterone receptor gene. Small inhibitory RNAs for cyclin D1 decreased progesterone receptor expression and estrogen receptor binding to the 3' enhancer region in human breast cancer cells. Since estrogen and progesterone regulate cyclin D1, our results suggest that cyclin D1's participation in a feed-forward loop could contribute to increased breast cancer risks associated with estrogen and progesterone combinations. Additionally, its regulation of the progesterone receptor identifies a novel role for cyclin D1 in ovarian hormone control of breast development and breast carcinogenesis.
Yang
Chuanwei
C
Cancer Research Center at Massachusetts General Hospital, 55 Fruit Street, GRJ 9th floor, Boston, MA 02114, USA.
Chen
Li
L
Li
Cuiqi
C
Lynch
Mary C
MC
Brisken
Cathrin
C
Schmidt
Emmett V
EV
D000818:Animals; D001665:Binding Sites; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D019938:Cyclin D1 / Q000378:metabolism*; D004742:Enhancer Elements, Genetic / Q000235:genetics; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D055785:Gene Knockdown Techniques; D006801:Humans; D006965:Hyperplasia / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D011374:Progesterone / Q000819:agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding / Q000187:drug effects; D034741:RNA, Small Interfering / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects
D004967:Estrogens; D034741:RNA, Small Interfering; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D019938:Cyclin D1; D011374:Progesterone; D004958:Estradiol
Mol Endocrinol. 2004 Sep;18(9):2196-207
15178746
Nucleic Acids Res. 1983 Mar 11;11(5):1475-89
6828386
J Biol Chem. 2002 Feb 15;277(7):5209-18
11717311
Steroids. 2008 Oct;73(9-10):914-21
18243264
Nature. 1994 Jun 23;369(6482):669-71
8208295
Cancer Cells. 1991 Nov;3(11):413-20
1760243
Cancer Cell. 2006 Jan;9(1):13-22
16413468
Nature. 1991 Apr 11;350(6318):512-5
1826542
Nucleic Acids Res. 2009 Jan;37(Database issue):D755-61
18996895
Endocrinology. 1997 Sep;138(9):3933-9
9275084
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9744-9
12897242
Oncogene. 2001 Aug 23;20(37):5093-9
11526497
J Biol Chem. 1998 Nov 6;273(45):29321-30
9792632
J Biol Chem. 2005 Jan 7;280(1):347-54
15509581
Histochem J. 1990 Oct;22(10):537-44
1705251
Cell. 2008 Mar 21;132(6):958-70
18358809
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3044-9
10737785
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14718-23
17785410
Oncogene. 1998 Jun 4;16(22):2865-78
9671407
Mol Cell Biol. 1997 Sep;17(9):5338-47
9271411
J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):95-104
15082921
Cancer Res. 2003 May 15;63(10):2425-33
12750262
Nature. 2001 Jun 28;411(6841):1017-21
11429595
Mol Endocrinol. 1993 Dec;7(12):1603-16
8145766
Cancer Res. 2006 Feb 1;66(3):1384-90
16452193
Steroids. 2007 Feb;72(2):188-201
17173941
Trans Med Chir Soc Edinb. 1896;15:153-179
29584099
Nat Genet. 2006 Nov;38(11):1289-97
17013392
Nature. 2010 Jan 21;463(7279):374-8
20090754
Endocrinology. 1999 Dec;140(12):5566-78
10579320
Mol Cell Endocrinol. 2003 Mar 28;201(1-2):165-75
12706304
Cell. 1997 Feb 7;88(3):405-15
9039267
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):709-13
8290586
J Endocrinol. 2006 Dec;191(3):537-48
17170212
J Clin Invest. 2000 May;105(10):1465-72
10811854
Development. 2007 Oct;134(20):3703-12
17881490
Genes Dev. 1998 Nov 15;12(22):3488-98
9832502
Cancer Res. 2006 Dec 15;66(24):11649-58
17178859
Cell. 2005 Jul 15;122(1):33-43
16009131
Mol Endocrinol. 1988 Feb;2(2):143-7
2840570
Endocrinology. 2005 Aug;146(8):3577-88
15878961
Mol Endocrinol. 1997 Oct;11(11):1593-607
9328342
Clin Cancer Res. 1997 Jun;3(6):849-54
9815758
N Engl J Med. 2009 Feb 5;360(6):573-87
19196674
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):696-701
9435255
Science. 2006 Dec 1;314(5804):1467-70
17138902
Mol Endocrinol. 2000 Jul;14(7):972-85
10894148
Mol Endocrinol. 2005 Jun;19(6):1402-11
15914709
J Biol Chem. 1997 Jun 27;272(26):16637-43
9195978
Bioinformatics. 2000 Aug;16(8):739-40
11099260
Cell. 1995 Aug 25;82(4):621-30
7664341